相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2015)
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes
Nilay M. Gandhi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Assessment of Tumoral PD-L1 Expression and Intratumoral CD8+T Cells in Urothelial Carcinoma
Sheila F. Faraj et al.
UROLOGY (2015)
Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
Alexander S. Baras et al.
PLOS ONE (2015)
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi et al.
CANCER CELL (2014)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Targeted therapies in urothelial carcinoma
Monalisa Ghosh et al.
CURRENT OPINION IN ONCOLOGY (2014)
Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder
E. Xylinas et al.
EJSO (2014)
Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic allterations and targets of therapy
Jeffrey S. Ross et al.
MODERN PATHOLOGY (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
Eliezer M. Van Allen et al.
CANCER DISCOVERY (2014)
PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases
L. B. Jilaveanu et al.
JOURNAL OF CANCER (2014)
Toward a Molecular Pathologic Classification of Urothelial Carcinoma
Gottfrid Sjodahl et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma
Myoung Jae Kang et al.
TRANSLATIONAL ONCOLOGY (2013)
Presence of Tumour-infiltrating FOXP3+ Lymphocytes Correlates with Immature Tumour Angiogenesis in Renal Cell Carcinomas
Hai-Lun Zhan et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
Ronald J. deLeeuw et al.
CLINICAL CANCER RESEARCH (2012)
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjodahl et al.
CLINICAL CANCER RESEARCH (2012)
Immunotherapy earns its spot in the ranks of cancer therapy
Drew Pardoll et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
David Lindgren et al.
PLOS ONE (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Localization of FOXP3-positive cells in renal cell carcinoma
Katharina Sell et al.
TUMOR BIOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
FOXP3 and survival in urinary bladder cancer
Malin E. Winerdal et al.
BJU INTERNATIONAL (2011)
Combined Gene Expression and Genomic Profiling Define Two Intrinsic Molecular Subtypes of Urothelial Carcinoma and Gene Signatures for Molecular Grading and Outcome
David Lindgren et al.
CANCER RESEARCH (2010)
Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression
David J. McConkey et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Increased Intratumoral FOXP3-positive Regulatory Immune Cells during Interleukin-2 Treatment in Metastatic Renal Cell Carcinoma
Hanne Krogh Jensen et al.
CLINICAL CANCER RESEARCH (2009)
Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications
Mahul B. Amin
MODERN PATHOLOGY (2009)
T-cell coregulatory molecule expression in urothelial cell carcinoma: Clinicopathologic correlations and association with survival
Stephen A. Boorjian et al.
CLINICAL CANCER RESEARCH (2008)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer
Anne B. Als et al.
CLINICAL CANCER RESEARCH (2007)
PD-L1 (B7-H1) expression by urothelial carcinoma of bladder and BCG-induced granulomata - Associations with localized stage progression
Brant A. Inman et al.
CANCER (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Chemotherapy for bladder cancer: Treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer
Cora N. Sternberg et al.
UROLOGY (2007)
Significance of B7-H1 overexpression in kidney cancer
R. Houston Thompson et al.
CLINICAL GENITOURINARY CANCER (2006)
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
RH Thompson et al.
CANCER RESEARCH (2006)
Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data
H Abol-Enein et al.
EUROPEAN UROLOGY (2005)
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
HB Grossman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Contemporary management of stage T1 transitional cell carcinoma of the bladder
MS Soloway et al.
JOURNAL OF UROLOGY (2002)
分享论文
